PRIVO TECHNOLOGIES

privo-technologies-logo

At Privo Technologies, they are developing an entirely new class of targeted treatments such as chemotherapy drugs, radiation sensitizers and radiation protectors and mitigators. Their proprietary nano-engineered platform is based on innovations in nanotechnology and material science discovered at MIT's Langer laboratory. Privo's platform is designed to create robust treatments for a wide range of indications while reducing or limiting the treatments harmful side effects. They deliver drugs via ... the mucosa with the initial focus on oral cavity mucosa. They are excited about building a pipeline of treatments with a range of product candidates in oncology, infectious diseases, and radiation. Their initial product candidate is a treatment for the critically underserved worldwide market of oral cancer. They are developing their novel targeted treatments for worldwide markets at their facilities in the greater Boston area.

#SimilarOrganizations #People #Financial #Website #More

PRIVO TECHNOLOGIES

Social Links:

Industry:
Biotechnology Health Care Medical Nanotechnology Therapeutics

Founded:
2009-01-01

Address:
Peabody, Massachusetts, United States

Country:
United States

Website Url:
http://www.privotechnologies.com

Total Employee:
11+

Status:
Active

Contact:
978-587-2322

Total Funding:
5.68 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon WordPress Google Maps ReCAPTCHA Sitelinks Search Box Yoast WordPress SEO Plugin Yoast Plugins


Similar Organizations

cabaletta-bio-logo

Cabaletta Bio

Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.

carisma-therapeutics-logo

Carisma Therapeutics

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.

enterin-logo

Enterin

Philadelphia-based biotechnology company .

eureka-therapeutics-logo

Eureka Therapeutics

Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.

halo-labs-logo

Halo Labs

Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.

tmunity-therapeutics-logo

Tmunity Therapeutics

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells

Current Employees Featured

manijeh-goldberg_image

Manijeh Goldberg
Manijeh Goldberg Founder and CEO @ Privo Technologies
Founder and CEO

Founder


manijeh-goldberg_image

Manijeh Goldberg

Investors List

national-cancer-institute_image

National Cancer Institute

National Cancer Institute investment in Grant - Privo Technologies

national-institute-of-dental-and-craniofacial-research-nidcr_image

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute of Dental and Craniofacial Research (NIDCR) investment in Grant - Privo Technologies

national-science-foundation_image

National Science Foundation

National Science Foundation investment in Grant - Privo Technologies

masschallenge_image

MassChallenge

MassChallenge investment in Grant - Privo Technologies

Official Site Inspections

http://www.privotechnologies.com Semrush global rank: 620.73 K Semrush visits lastest month: 51.48 K

  • Host name: s-vps-il-898.upress.io
  • IP address: 185.201.148.160
  • Location: Israel
  • Latitude: 31.5
  • Longitude: 34.75
  • Timezone: Asia/Jerusalem

Loading ...

More informations about "Privo Technologies"

About Us - Privo Technologies, Inc.

Privo Technologies is a biotechnology company that consists of dedicated scientists, researchers, engineers, and biotech entrepreneurs who all have โ€ฆSee details»

Pipeline - Privo Technologies, Inc.

Our dynamic pipeline showcases the versatility and potential of our cutting-edge platform technology. Anchored in a robust foundation, our pipeline boasts four โ€ฆSee details»

Privo Technologies - Crunchbase Company Profile

Privo Technologies is a development-stage biotechnology company located โ€ฆSee details»

Privo Technologies, Inc. To Present at the 24th Annual BIO CEO ...

Feb 4, 2022 Another derivative, PRV211, is a sterilized, rapid release chemotherapy patch that can be applied intraoperatively post-tumor resection to potentially reduce the risk of cancer โ€ฆSee details»

Privo Technologies Company Profile - Office Locations ... - Craft

Privo Technologies has 5 employees at their 1 location. See insights on Privo Technologies including office locations, competitors, revenue, financials, executives, subsidiaries and more โ€ฆSee details»

PRV System - Privo Technologies, Inc.

Privoโ€™s cutting-edge PRV platform technology is a culmination of 12 years of research and development at MITโ€™s prestigious Bob Langer Lab and Privoโ€™s โ€ฆSee details»

Prive Technologies | Modular Wealth Management โ€ฆ

Our innovative SaaS platform equips financial institutions with the tools to supercharge their wealth and investment strategies. From hyper-personalized โ€ฆSee details»

News - Privo Technologies, Inc.

Privo Technologies Inc. Announces the Launch of BeneVet Oncology: Advancing Companion Animal Health Through Innovation Privo Technologies Inc., a โ€ฆSee details»

Team - Privo Technologies, Inc.

Albert Collinson, PH.D BUSINESS DEVELOPMENT ADVISOR Dr. Collinson has over 35 years of experience in the pharmaceutical and biotechnology โ€ฆSee details»

Privo Technologies 2025 Company Profile: Valuation, Funding

Information on valuation, funding, cap tables, investors, and executives for Privo Technologies. Use the PitchBook Platform to explore the full profile.See details»

Privo Technologies - Work in biotech

Privo Technologies is developing innovative therapeutics to eliminate cancers and prevent recurrence. To enhance both existing cancer therapies as well as developing novel ones, โ€ฆSee details»

Privo Technologies Inc - LinkedIn

Privo Technologies Inc | 802 followers on LinkedIn. Phase 3 Oncology Biotech Company | Privo Technologies is a privately funded, Phase III oncology company that spun out of the world โ€ฆSee details»

Privo Technologies Inc Company Overview, Contact Details

Feb 25, 2022 Privo Technologies Inc 's official website is privotechnologies.com and has social profiles on LinkedIn. What is Privo Technologies Inc's SIC code NAICS code? Privo โ€ฆSee details»

Privo Technologies, Inc. - Drug pipelines, Patents, Clinical trials ...

Jun 18, 2023 Explore Privo Technologies, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 7 news, Disease Domain:Neoplasms, Technology ...See details»

Overview, News & Similar companies - ZoomInfo.com

Nov 8, 2023 View Privo Technologies (www.privotechnologies.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well โ€ฆSee details»

Privo Technologies - News & Analysis - Crunchbase

Mar 24, 2025 77 15721 86 Founded 2009Private Grant Peabody, Massachusetts, United States 11-50 www.privotechnologies.com Biotechnology Health Care Medical Nanotechnology โ€ฆSee details»

Privo Technologies - 2025 Company Profile - Tracxn

Mar 28, 2025 Privo Technologies is a funded company based in Peabody (United States), founded in 2009 by Manijeh Goldberg. It operates as a Provider of nanotechnology-based โ€ฆSee details»

Privo Technologies - Products, Competitors, Financials, Employees ...

Privo Technologies is a biotechnology company that develops oncology therapeutics using a nanotechnology-based drug delivery platform. Use the CB Insights Platform to explore Privo โ€ฆSee details»

Privo Technologies Stock Price, Funding, Valuation, Revenue

Feb 25, 2022 See Privo Technologies funding rounds, investors, investments, exits and more. Evaluate their financials based on Privo Technologies's post-money valuation and revenue.See details»

Privo Technologies Inc. Announces the Launch of BeneVet โ€ฆ

Mar 24, 2025 Privo Technologies Inc., a pioneering biopharmaceutical company known for its innovative approach to drug delivery and cancer treatment, is proud to announce the launch of โ€ฆSee details»

linkstock.net © 2022. All rights reserved